510(k) · Cleared
ClearedHemoTrol WB - Low, HemoTrol WB - Normal, HemoTrol WB - High
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Eurotrol B.V. · GGM Control, Hemoglobin
Cleared on Feb 1, 2019 as substantially equivalent to K964052 (Direct Solutions, 1996) after a 126-day review. Its family tree reaches back 1 generation to 1996. 1 later device descends from it.
- Decided
- Feb 1, 2019
- Review
- 126 days
- Class
- Class II
- Product code
- GGM
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K964052 (1996). 1 later device descends from it, 1 citing it directly.
- Root · 1 generation backK964052 Hemocue HemotrolDirect Solutions · 1996 · Recalled
- This deviceK182744 HemoTrol WB - Low, HemoTrol WB - Normal, HemoTrol WB - HighEurotrol B.V. · 2019
- Descendant · cites it directly · 0 of its ownK192842 HemoTrol Duo Low, HemoTrol Duo Normal, HemoTrol Duo HighEurotrol B.V. · 2019
Most influential descendants
Showing 1 of 1 · See all- K192842HemoTrol Duo Low, HemoTrol Duo Normal, HemoTrol Duo HighEurotrol B.V. · 2019 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K964052 | Hemocue Hemotrol | Direct Solutions | 1996 | 2 |
| 0 (this device) | K182744 | HemoTrol WB - Low, HemoTrol WB - Normal, HemoTrol WB - High | Eurotrol B.V. | 2019 | — |
| +1 | K192842 | HemoTrol Duo Low, HemoTrol Duo Normal, HemoTrol Duo High | Eurotrol B.V. | 2019 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2019 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GGM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K964052 | Hemocue HemotrolSummary page 4…GGM – control, Hemoglobin HemoTrol ® WB – High 08718734960966 Predicate Device Eurotrol HemoTrol 510(k) number: K964052 Device Description HemoTrol® WB is an assayed hemoglobin quality control material intended for professional use in the verifi… | 1996 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K192842 | HemoTrol Duo Low, HemoTrol Duo Normal, HemoTrol Duo High | 2019 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has a recall.
- Of its descendants, K192842 (Eurotrol B.V., 2019) has gone furthest, with 0 descendants of its own.
How does its category compare?
All GGM devicesGGM Control, Hemoglobin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.
FDA decisions per year · GGM
2in 2019
2026 to Oct 25, outlined.
Median 510(k) review, days · GGM
Too few GGM 510(k)s in any year since 2007 to give a median.
Recalls per year · GGM
2in 2018
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GGM
1in 2018
MAUDE reports naming product code GGM, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 1 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 2 | 1 |
| 2019 | 2 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
HemoTrol® WB is an assayed quality control material for professional use to verify the performance characteristics of the HemoCue ® Hb 301 and the HemoCue ® Hb 801 System. HemoTrol® WB is intended for the quantitative determination of hemoglobin.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K182744 · printed Nov 4, 2026
Cite this page
510(k) Report. “K182744: HemoTrol WB - Low, HemoTrol WB - Normal, HemoTrol WB - High.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K182744
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026